| 2026-01-06 |
复牌提示：
2026-01-05 19:50:00 停牌，复牌日期 2026-01-07 00:00:01
|
| 2025-11-24 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.72欧元,归母净利润1.62亿欧元,同比去年增长-17.11%
|
| 2025-10-27 |
股东大会：
将于2025-11-25召开股东大会
会议内容 ▼▲
- 1.Opening
2.Explanation of the exchange offer by BioNTech SE (“Buyer”) for ordinary shares in the capital of the Company (the “Offer”) (discussion item)
3.Consummation of post-offer reorganization (voting items)
a.Conditional resolution to enter into a legal merger (juridische fusie) of the Company (as disappearing company) with and into CureVac Merger B.V. (as acquiring company surviving such merger) (“New Topco”), with New Topco issuing class A shares in its capital to the Company’s shareholders (other than Buyer) and class B shares in its capital to Buyer, in accordance with Sections 2:309 et seq. of the Dutch Civil Code (the “Legal Downstream Merger”)
b.Conditional resolution to approve, to the extent required under applicable law and the Company’s articles of association and bylaws (reglementen), (i) the Legal Downstream Merger, (ii) the subsequent sale and transfer of all outstanding shares in the capital of CureVac SE by New Topco to Buyer and (iii) the subsequent cancellation of all outstanding class A shares in the capital New Topco
4.Conditional release from liability (voting items)
a.Conditional release of managing directors from liability for the exercise of their duties
b.Conditional release of supervisory directors from liability for the exercise of their duties
5.Conditional appointment of Ramón Zapata Gomez as managing director of the Company (voting item)
6.Conditional appointment of supervisory directors (voting items)
a.Conditional appointment of Sierk Poetting as supervisory director of the Company
b.Conditional appointment of James Ryan as supervisory director of the Company
c.Conditional appointment of Annemarie Hanekamp as supervisory director of the Company
7.Closing
|
| 2025-08-15 |
详情>>
业绩披露：
2025年中报每股收益-0.5欧元,归母净利润-1.12亿欧元,同比去年增长21.98%
|
| 2025-06-16 |
详情>>
股本变动：
变动后总股本22517.27万股
|
| 2025-05-23 |
股东大会：
将于2025-06-24召开股东大会
会议内容 ▼▲
- 1.Opening;
2.Discussion of the annual report over the financial year 2024 (discussion item);
3.Adoption of the annual accounts over the financial year 2024 (voting item);
4.Explanation of the dividend and reservation policy (discussion item);
5.Release of managing directors from liability for the exercise of their duties during the financial year 2024 (voting item);
6.Release of supervisory directors from liability for the exercise of their duties during the financial year 2024 (voting item);
7.Appointment of Axel Sven Malkomes as member of the Company′s management board (voting item);
8.Reappointment of Jean Stéphenne as member of the Company's supervisory board (voting item);
9.Appointment of Mehdi Shahidi as member of the Company's supervisory board (voting item);
10.Reappointment of Debra Barker as member of the Company's supervisory board (voting item);
11.Reappointment of Craig A. Tooman as member of the Company's supervisory board (voting item);
12.Reappointment of Klaus Schollmeier as member of the Company's supervisory board (voting item);
13.Reappointment of the external auditor for the financial year 2026 (voting item);
14.Authorisation of the management board to issue shares and to grant rights to subscribe for shares in the Company's capital (voting item);
15.Authorisation of the management board to limit or exclude pre-emption rights (voting item);
16.Amendment to the compensation of the members of the Company’s supervisory board (voting item);
17.Closing.
|
| 2025-05-20 |
详情>>
业绩披露：
2025年一季报每股收益-0.23欧元,归母净利润-5208.4万欧元,同比去年增长26.18%
|
| 2025-04-11 |
详情>>
业绩披露：
2022年年报每股收益-1.32欧元,归母净利润-2.49亿欧元,同比去年增长39.51%
|
| 2025-04-11 |
详情>>
业绩披露：
2024年年报每股收益0.72欧元,归母净利润1.62亿欧元,同比去年增长162.34%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.87欧元,归母净利润1.95亿欧元,同比去年增长212.35%
|
| 2024-11-12 |
财报披露：
美东时间 2024-11-12 盘前发布财报
|
| 2024-08-15 |
详情>>
业绩披露：
2024年中报每股收益-0.64欧元,归母净利润-1.43亿欧元,同比去年增长-14.63%
|
| 2024-05-24 |
股东大会：
将于2024-06-24召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the annual report over the financial year 2023 (discussion item).
3.Adoption of the annual accounts over the financial year 2023 (voting item).
4.Explanation of the dividend and reservation policy (discussion item).
5.Release of managing directors from liability for the exercise of their duties during the financial year 2023 (voting item).
6.Release of supervisory directors from liability for the exercise of their duties during the financial year 2023 (voting item).
7.Appointment of Thaminda Ramanayake as member of the Company′s management board (voting item).
8.Reappointment of Malte Greune as member of the Company's management board (voting item).
9.Reappointment of Jean Stéphenne as member of the Company's supervisory board (voting item).
10.Reappointment of Mathias Hothum as member of the Company's supervisory board (voting item).
11.Appointment of Birgit Hofmann as member of the Company's supervisory board (voting item).
12.Reappointment of the external auditor for the financial year 2025 (voting item).
13.Closing
|
| 2024-05-23 |
详情>>
业绩披露：
2024年一季报每股收益-0.31欧元,归母净利润-7055.3万欧元,同比去年增长-22.87%
|
| 2024-04-25 |
详情>>
业绩披露：
2023年年报每股收益-1.18欧元,归母净利润-2.6亿欧元,同比去年增长-4.47%
|
| 2024-04-25 |
详情>>
业绩披露：
2021年年报每股收益-2.21欧元,归母净利润-4.12亿欧元,同比去年增长-218.86%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.79欧元,归母净利润-1.74亿欧元,同比去年增长-44.3%
|
| 2023-05-30 |
股东大会：
将于2023-06-19召开股东大会
会议内容 ▼▲
- 1.Opening.
2.Discussion of the annual report over the financial year 2022 (discussion item).
3.Adoption of the annual accounts over the financial year 2022 (voting item).
4.Explanation of the dividend and reservation policy (discussion item).
5.Release of managing directors from liability for the exercise of their duties during the financial year 2022 (voting item).
6.Release of supervisory directors from liability for the exercise of their duties during the financial year 2022 (voting item).
7.Appointment of Michael Brosnan as member of the Supervisory Board (voting item).
8.Appointment of the external auditor for the financial year 2024 (voting item).
9.Closing.
|
| 2023-05-30 |
股东大会：
将于2023-06-19召开股东大会
会议内容 ▼▲
- 1.Opening.
2.Discussion of the annual report over the financial year 2022 (discussion item).
3.Adoption of the annual accounts over the financial year 2022 (voting item).
4.Explanation of the dividend and reservation policy (discussion item).
5.Release of managing directors from liability for the exercise of their duties during the financial year 2022 (voting item).
6.Release of supervisory directors from liability for the exercise of their duties during the financial year 2022 (voting item).
7.Appointment of Michael Brosnan as member of the Supervisory Board (voting item).
8.Appointment of the external auditor for the financial year 2024 (voting item).
9.Closing.
|
| 2022-06-01 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the annual report over the financial year 2021 (discussion item)
3.Adoption of the annual accounts over the financial year 2021 (voting item)
4.Explanation of the dividend and reservation policy (discussion item)
5.Release of managing directors from liability for the exercise of their duties during the financial year 2021 (voting item)
6.Release of supervisory directors from liability for the exercise of their duties during the financial year 2021 (voting item)
7.Re-appointment of Dr. Franz-Werner Haas as managing director and chair of the Management Board (voting item)
8.Appointment of Dr. Malte Greune as managing director of the Management Board, COO (voting item)
9.Appointment of Dr. Klaus Schollmeier as member of the Supervisory Board (voting item)
10.Re-appointment of Craig Allen Tooman as member of the Supervisory Board (voting item)
11.Appointment of Dr. Debra Barker as member of the Supervisory Board (voting item)
12.Appointment of the external auditor for the financial year 2023 (voting item)
13.Closing
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-04 |
股东大会：
将于2021-06-24召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the annual report over the financial year 2020 (discussion item)
3.Adoption of the annual accounts over the financial year 2020 (voting item)
4.Explanation of the dividend and reservation policy (discussion item)
5.Appointment of Mr. Antony Blanc as managing director (voting item)
6.Appointment of Mr. Klaus Edvardsen as managing director (voting item)
7.Re-appointment of Mr. Pierre Kemula as managing director (voting item)
8.Appointment of Mr. Ingmar Hoerr as supervisory director (voting item)
9.Equity award to Mr. Jean Stéphenne as compensation for his services as supervisory director (voting item)
10.Equity award to Mr. Ralf Clemens as compensation for his services as supervisory director (voting item)
11.Release of managing directors from liability for the exercise of their duties during the financial year 2020 (voting item)
12.Release of supervisory directors from liability for the exercise of their duties during the financial year 2020 (voting item)
13.Authorization of the management board to acquire shares (or depository receipts for shares) in the Company's capital (voting item)
14.Compensation of supervisory directors (voting item)
15.Appointment of the external auditor for the financial year 2022 (voting item)
16.Closing
|